What is it?
Pollen, a substance collected from the flowers of various plants, contains carbohydrates,
fat, protein, and some vitamins and minerals.1
A proprietary rye pollen extract (Cernilton®) has been shown to have anti-inflammatory
properties,2 to relax the muscles that surround the urethra,3 and to
inhibit growth of prostate cells.4 This rye pollen extract has been reported to
improve symptoms of chronic prostatitis in
uncontrolled trials,5 6 7 including a trial in which three
tablets daily significantly reduced symptoms in 78% of people with uncomplicated prostatitis.
However, only one of eighteen people with complications (such as scar tissue and
calcifications) improved.8
Preliminary9 10 11 and double-blind12
13 14 trials have demonstrated that a proprietary rye pollen extract is
effective at reducing the symptoms of benign prostatic hyperplasia.
A preliminary report from the Ukraine on the use of flower pollen in humans with rheumatoid arthritis suggested positive effects on
related disorders of the liver, gallbladder, stomach, and intestine.15 Pollen
extracts have been used orally to desensitize people to plants to which they are allergic.16 17 18
19 20 For example, in a double-blind study, people with hay fever allergies to grass pollen were asked to
place drops of liquid grass pollen extract under their tongues daily for three weeks, using a
gradually increasing concentration. After the three-week period, pollen was given twice per
week at a "maintenance" level. During the next allergy season they had significantly fewer
severe hay fever symptoms than a group given placebo drops.21
Melbrosia, a mixture of flower pollen, fermented bee pollen, and royal jelly, was reported to help relieve menopausal symptoms in about one-third of women in an
uncontrolled survey in Denmark.22 This result agrees with an earlier, controlled
study that found melbrosia (amount not stated) was more effective than a placebo for
menopausal symptoms, including headache, urinary incontinence, vaginal dryness, and low
vitality.23 According to animal studies, melbrosia does not work by causing oestrogen-like effects in body
tissues.24 Whether royal jelly alone might have similar effects on menopausal
symptoms is unknown.
1. Stanley RG, Liskens HF. Pollens. Springer-Verlag: New York,
1974.
2. Loschen G, Ebeling L. Inhibition of arachidonic acid cascade by
extract of rye pollen. Arzneimittelforschung 1991;41:162–7 [in German].
3. Nakase K, Takenaga K, Hamanaka T, et al. Inhibitory effect and
synergism of cernitin pollen extract on the urethral smooth muscle and diaphragm of the rat.
Nippon Yakurigaku Zasshi 1988 Jun;91:385–92 [in Japanese].
4. Habib FK, Ross M, Buck AC, et al. In vitro evaluation of the pollen
extract, cernitin T-60, in the regulation of prostate cell growth. Br J Urol
1990;66:393–7.
5. Jodai A, Maruta N, Shimomae E, et al. A long-term therapeutic
experience with Cernilton in chronic prostatitis. Hinyokika Kiyo 1988;34:561–8
[in Japanese].
6. Ohkoshi M, Kawamura N, Nagakubo I. Clinical evaluation of Cernilton in
chronic prostatitis. Jpn J Clin Urol 1967;21:73–6.
7. Suzuki T, Kurokawa K, Mashimo T, et al. Clinical effect of Cernilton
in chronic prostatitis. Hinyokika Kiyo 1992;38:489–94 [in Japanese].
8. Rugendorff EW, Weidner W, Ebeling L, et al. Results of treatment with
pollen extract (Cernilton N) in chronic prostatitis and prostatodynia. Br J Urol
1993;71:433–8.
9. Horii A, Iwai S, Maekawa M, Tsujita M. Clinical evaluation of
Cernilton in the treatment of the benign prostatic hypertrophy. Hinyokika Kiyo
1985;31:739–46 [in Japanese].
10. Ueda K, Jinno H, Tsujimura S. Clinical evaluation of Cernilton®
on benign prostatic hyperplasia. Hinyokika Kiyo 1985;31:187–91 [in
Japanese].
11. Hayashi J, Mitsui H, Yamakawa G, et al. Clinical evaluation of
Cernilton in benign prostatic hypertrophy. Hinyokika Kiyo 1986;32:135–41 [in
Japanese].
12. Becker H, Ebeling L. Conservative therapy of benign prostatic
hyperplasia (BPH) with Cernilton. Urologe (B) 1988;28:301–6 [in German].
13. Buck AC, Cox R, Rees RW, et al. Treatment of outflow tract
obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A
double-blind, placebo-controlled study. Br J Urol 1990;66:398–404.
14. Maekawa M, Kishimoto T, Yasumoto R, et al. [Clinical evaluation of
Cernilton on benign prostatic hypertrophy—a multiple center double-blind study with
Paraprost]. Hinyokika Kiyo 1990;36:495–516 [in Japanese].
15. Voloshyn OI, Pishak OV, Seniuk BP, et al. The efficacy of flower
pollen in patients with rheumatoid arthritis and concomitant diseases of the gastroduodenal
and hepatobiliary systems. Likarska Sprava 1998;4:151–4 [in Ukrainian].
16. Vourdas D, Syrigou E, Potamianou P, et al. Double-blind,
placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen
extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive
pollen sensitization. Allergy 1998;53:662–72.
17. Horak F, Stubner P, Berger UE, et al. Immunotherapy with sublingual
birch pollen extract. A short-term double-blind placebo study. J Investig Allergol Clin
Immunol 1998;8:165–71.
18. Ariano R, Panzani RC, Augeri G. Efficacy and safety of oral
immunotherapy in respiratory allergy to Parietaria judaica pollen. A double-blind study. J
Investig Allergol Clin Immunol 1998;8:155–60.
19. Clavel R, Bousquet J, Andre C. Clinical efficacy of
sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized
five-grass-pollen extract in rhinitis. Allergy 1998;5:493–8.
20. Litwin A, Flanagan M, Entis G, et al. Oral immunotherapy with short
ragweed extract in a novel encapsulated preparation: a double-blind study. J Allergy Clin
Immunol 1997;100:30–8.
21. Hordijk GJ, Antvelink JB, Luwema RA. Sublingual immunotherapy with a
standardised grass pollen extract; a double-blind placebo-controlled study. Allergol
Immunopathol (Madr) 1998;26:234–40.
22. Kristoffersen K, Thomsen BW, Schacke E, Wagner HH. Use of natural
medicines in women referred to specialists. Ugeskr Laeger 1997;159:294–6 [in
Danish].
23. Szanto E, Gruber D, Sator M, et al. Placebo-controlled study of
melbrosia in treatment of climacteric symptoms. Wien Med Wochenschr
1994;144:130–3 [in German].
24. Einer-Jensen N, Zhao J, Andersen KP, Kristoffersen K. Cimicifuga and
Melbrosia lack oestrogenic effects in mice and rats. Maturitas
1996;25:149–53.
25. Cohen SH, Yunginger JW, Rosenberg N, Fink JN. Acute allergic reaction
after composite pollen ingestion. J Allergy Clin Immunol 1979;64:270.
26. Mansfield LE, Goldstein GB. Anaphylactic reaction after ingestion of
local bee pollen. Ann Allergy 1981;47:154–6.
27. Noyes JH, Boyd GK, Settipane GA. Anaphylaxis to sunflower seed. J
Allergy Clin Immunol 1979;63:242–4.